Status:
UNKNOWN
A Study on the Effectiveness of Tuina in Managing Chronic Low Back Pain
Lead Sponsor:
Singapore General Hospital
Collaborating Sponsors:
The Head Foundation
Conditions:
Chronic Low-back Pain
Eligibility:
All Genders
21-75 years
Phase:
NA
Brief Summary
Low back pain (LBP) is a common clinical symptom prompting patients to seek medical care. 80% of adults experience LBP during their lifetime. The causes of CNLBP are still not fully elucidated and the...
Detailed Description
This is a randomised controlled study, single blind with the assessor blinded to the intervention groups of the study. 204 patients (68 per group) with CNLBP will be recruited from the Outpatient Spi...
Eligibility Criteria
Inclusion
- Voluntary participants aged 21 to 75 years old, regardless of gender, who has CNLBP according to the specific diagnostic criteria below:
- Pain and discomfort of unknown etiology in the low back region, (with or without referred pain to the lower limbs), lasting for more than 12 weeks.
- There may be muscle weakness, stiffness, limited mobility or reduced spinal coordination during spinal movement.
- Physical examination showed an increase in muscle tension or a significant localized tenderness point (trigger point) in the painful area, with negative straight-leg raising test, and no signs of nerve root lesion
Exclusion
- Patients with severe skin diseases (e.g., skin cancer, erysipelas, severe eczema, severe dermatitis, severe psoriasis and severe hives lupus).
- Recent (within the last month) episodes of spinal pathologies such as fractures, tumors, inflammatory and infectious diseases.
- History of spine surgery.
- Recent (within the last month) episodes of cardiovascular or metabolic disorders.
- Patients diagnosed with psychosocial factors affecting the cognitive and mental faculties such as major depression, moderate to severe dementia and severe psychiatric diseases (such as schizophrenia, bipolar affective disorder, and paranoid psychosis).
- Women who are Pregnant.
- Full-time National Service men or on workmen compensation.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2023
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT05363579
Start Date
March 1 2021
End Date
May 31 2023
Last Update
May 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore General Hospital
Singapore, Singapore, 169608